Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The bitter pill.

C Djerassi1

  • 1Stanford University, CA 94305.

Science (New York, N.Y.)
|July 28, 1989
PubMed
Summary
This summary is machine-generated.

New contraceptive methods like a male pill or antifertility vaccine require reversing the pharmaceutical industry

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phospholpid studies of marine organisms: 2.(1) Phospholipids, phospholipid-bound fatty acids and free sterols of the spongeAplysina fistularis (Pallas) formafulva (Pallas) (=Verongia thiona)(2). Isolation and structure elucidation of unprecedented branched fatty acids.

Lipids·2016
Same author

Phospholipid studies of marine organisms: V(1) new α-methoxy acids fromHigginsia tethyoides.

Lipids·2016
Same author

The preparation and partial aromatization of 1,4-cholestadienone-3 by the dienonephenol rearrangement.

Journal of the American Chemical Society·2010
Same author

The dienonephenol rearrangement applied to chrysene derivatives; the synthesis of 3-hydroxy-1-methylchrysene and related compounds.

Journal of the American Chemical Society·2010
Same author

Heterocyclic amines with antithistaminic activity.

Journal of the American Chemical Society·2010
Same author

The synthesis of estradiol and l-methylestradiol from cholesterol.

Journal of the American Chemical Society·2010
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

Area of Science:

  • Reproductive Health
  • Pharmaceutical Development
  • Contraceptive Technology

Background:

  • The development of novel birth control methods is crucial for reproductive health.
  • The pharmaceutical industry has significantly reduced its involvement in contraceptive research and development.
  • Existing contraceptive options have limitations, necessitating innovation.

Purpose of the Study:

  • To assess the feasibility of fundamentally new birth control approaches.
  • To identify key factors influencing the advancement of contraceptive technologies.
  • To explore incentives for pharmaceutical industry re-engagement in birth control development.

Main Methods:

  • Analysis of historical trends in contraceptive research.
  • Evaluation of the impact of regulatory and economic factors on pharmaceutical investment.

Related Experiment Videos

  • Identification of potential new contraceptive modalities, including male contraception, menses inducers, and vaccines.

    • Main Results:

    • Fundamentally new birth control methods are unlikely to be available within the current century.
    • The withdrawal of the pharmaceutical industry from this field is a major impediment.
    • Significant changes in product liability regulations are identified as a primary incentive for industry re-engagement.

    Conclusions:

    • Advancement in contraceptive technology is critically dependent on reversing the pharmaceutical industry's withdrawal.
    • Product liability reform is essential to encourage investment in novel birth control solutions.
    • Future development of male pills, menses inducers, and antifertility vaccines hinges on addressing industry concerns.